Soewondo Widiastuti, Adzhani Fityay, Hanafi Muchtar, Firdaus Zaka J
Department of Radiology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.
Department of Radiology, Dr. Moewardi Hospital, Surakarta, Indonesia.
Narra J. 2024 Aug;4(2):e1024. doi: 10.52225/narra.v4i2.1024. Epub 2024 Aug 31.
Previous studies have associated tumor size with metastasis and prognosis in lung carcinoma; however, a precise cut-off for predicting distant metastasis in lung adenocarcinoma remains unclear. The aim of this study was to determine the cut-off point for predicting distant metastasis in lung adenocarcinoma. A cross-sectional study was conducted at Dr. Moewardi Hospital, Surakarta, Indonesia, from January 2022 to September 2023. Total sampling was employed, involving patients over 18 years old with a confirmed diagnosis of lung adenocarcinoma based on lung computed tomography (CT) scan findings, who had not yet received chemotherapy and had confirmed metastasis outside the lung. The study's dependent variable was the incidence of distant metastasis, while the independent variable was lung adenocarcinoma size. Two experienced thoracic radiologists measured lung adenocarcinoma size by assessing the longest axis using chest multi-slice computed tomography (MSCT) in the lung window setting. Receiver operating characteristic (ROC) curve analysis determined the optimal tumor size cut-off for predicting distant metastasis. Of 956 thoracic cancer patients, 108 were diagnosed with lung adenocarcinoma. After applying the inclusion and exclusion criteria, 89 patients were eligible. In the present study, tumor size predicted 68.1% of distant metastasis cases, with a cut-off point of 7.25 cm, yielding a sensitivity of 61.9% and a specificity of 61.5%. Tumors >7.25 cm had a 2.60-fold higher risk of distant metastasis compared to smaller tumors, with larger tumors more likely to spread to various sites. In conclusion, lung adenocarcinomas larger than 7.25 cm have a 2.60-fold increased risk of distant metastasis, making tumor size a crucial predictive factor. The study provides valuable insights for radiologists and can improve diagnosis accuracy and treatment planning by emphasizing tumor size as a key factor in managing lung adenocarcinoma.
以往的研究已将肿瘤大小与肺癌的转移及预后相关联;然而,预测肺腺癌远处转移的精确临界值仍不明确。本研究的目的是确定预测肺腺癌远处转移的临界值。2022年1月至2023年9月在印度尼西亚梭罗市的莫瓦迪医院开展了一项横断面研究。采用全样本抽样,纳入年龄超过18岁、基于肺部计算机断层扫描(CT)扫描结果确诊为肺腺癌、尚未接受化疗且已确诊存在肺外转移的患者。该研究的因变量是远处转移的发生率,自变量是肺腺癌大小。两名经验丰富的胸科放射科医生通过在肺窗设置下使用胸部多层计算机断层扫描(MSCT)评估最长径来测量肺腺癌大小。受试者工作特征(ROC)曲线分析确定了预测远处转移的最佳肿瘤大小临界值。在956例胸癌患者中,108例被诊断为肺腺癌。应用纳入和排除标准后,89例患者符合条件。在本研究中,肿瘤大小可预测68.1%的远处转移病例,临界值为7.25 cm,敏感性为61.9%,特异性为61.5%。与较小肿瘤相比,直径>7.25 cm的肿瘤发生远处转移的风险高2.60倍,较大肿瘤更易扩散至多个部位。总之,直径大于7.25 cm的肺腺癌发生远处转移的风险增加2.60倍,这使得肿瘤大小成为一个关键的预测因素。该研究为放射科医生提供了有价值的见解,并通过强调肿瘤大小是管理肺腺癌的关键因素,可提高诊断准确性和治疗规划水平。